Mr. Kåre Schultz is President & Chief Executive Officer at Lundbeck Pharma A/S and Chairman at Royal Unibrew A/S.
He is on the Board of Directors at Teva Pharmaceutical Industries Ltd., LEGO A/S, Bitten og Mads Clausens Fond and Danfoss A/S. Mr. Schultz was previously employed as President & Chief Executive Officer by H. Lundbeck A/S and President & Chief Operating Officer by Novo Nordisk A/S.
He also served on the board at LEGO Holding A/S and LEGO System A/S.
He received his graduate degree from the University of Copenhagen.